On December 8, Fuan Pharmaceutical announced that its subsidiary product, paramivir injection, was newly included in the 2025 “National Medical Insurance Drug Catalogue” to treat influenza A or B.

Zhitongcaijing · 2d ago
On December 8, Fuan Pharmaceutical announced that its subsidiary product, paramivir injection, was newly included in the 2025 “National Medical Insurance Drug Catalogue” to treat influenza A or B.